Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0773 in women with sarcopenia
NCT00529659Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2007
- Primary completion
- Oct 2009
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of MK-0773 in Sarcopenia, sponsored by Merck & Co.. Started Oct 2007; status: completed.
02
Drugs
MK-0773
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on NCT00529659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00529659.